Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma-Reference-Cited by-同舟云学术

Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Published:2020-12 Issue:12 Volume:20 Page:797-803
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kaufman Jonathan L.,Mina Roberto^ORCID,Shah Jatin J.,Laubach Jacob P.,Nooka Ajay K.,Lewis Colleen,Gleason Charise,Sharp Cathy^ORCID,Harvey R. Donald,Heffner Leonard T.,Richardson Paul,Lonial Sagar,Orlowski Robert Z.

Funder

Novartis

Onyx

Celgene

Millennium

Pharmacyclics

Genentech

Amgen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. NCCN guidelines insights: multiple myeloma, version 3.2018;Kumar;J Natl Compr Canc Netw,2018

2. Is there still a role for stem cell transplantation in multiple myeloma?;Mina;Cancer,2019

3. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival;Lahuerta;J Clin Oncol,2008

4. Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma;van de Velde;Haematologica,2007

5. Depth of response in multiple myeloma: a pooled analysis of three PETHEMA/GEM clinical trials;Lahuerta;J Clin Oncol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma;Haematologica;2023-08-24

2. Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma;International Journal of Molecular Sciences;2023-01-31

3. Therapeutic potential of HDAC inhibitors in the treatment of cardiac diseases: A short review;Current Drug Targets;2022-10-03

4. Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications;Cancers;2021-08-13

5. Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy;Marine Drugs;2020-12-31